Eris Lifesciences

Eris Lifesciences

World Rank (Jan-05-2024)
6,710
Market Cap (Jan-05-2024)
1.518 Billion USD
World Rank (Jul-30-2023)
7,521
Market Cap (Jul-30-2023)
1.283 Billion USD
World Rank (Jan-07-2022)
7,843
Market Cap (Jan-07-2022)
1.370 Billion USD
World Rank (Jan-01-2021)
7,593
Market Cap (Jan-01-2021)
1.096 Billion USD
Company Rank in Country in 2023
Rank in India in July-2023 is 370
Headquarters Country
India
Market Cap (Mar-08-2026)
2.01
Employee Count
4,044
Employee Count as of Date
As on March 2020, it has 2,239 Permanent Employees and remaining are Contractual Employees
World Region
Asia
World Subregion
Southern Asia
Annual Revenue in USD
166 Million USD
Annual Net Income in USD
51 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
284 Million USD
Total Liabilities in USD
46 Million USD
Total Equity in USD
239 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
HealthCare Products
Pharmaceutical
Company Website
Eris LifeSciences Ltd
Yahoo
Yahoo @ BSE
Company Profile
Eris Lifesciences is a pharmaceutical company with a generation of actionable medical evidence through initiatives such as the India Heart Study (IHS) and India Diabetes Study (IDS). The company annual revenue is 13,470 million INR and annual net income is 4,061 million INR for year ending March 2021. The headquarters is in India.
ISIN Code
INE406M01024
Stock Category
S&P BSE HEALTH CARE
Stock Exchange
BSE
NSE
Company SubCategory
Top Healthcare Companies in India

Share